SEI Investments
GEVA

SEI Investments’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

SEI Investments’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-462
Closed -$45K – 2459
2015
Q1 		$45K Sell
462
-62
-12% -$6.56K ﹤0.01% 1705
2014
Q4 		$49K Buy
+524
New +$41.4K ﹤0.01% 1701

SEI Investments's GEVA Position: Q2 2015 in Review

SEI Investments sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 462 shares — an estimated $45K sold.

SEI Investments first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $49K in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • SEI Investments reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • SEI Investments sold 462 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $45K.
  • SEI Investments first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • SEI Investments's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $49K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on SEI Investments's 13F filing for Q2 2015, filed 4 Aug 2015.